ChemicalBook >> CAS DataBase List >>TocilizuMab
TocilizuMab
- CAS No.
- 375823-41-9
- Chemical Name:
- TocilizuMab
- Synonyms
- Actemra;Atlizumab;R 1569;RoActemra;Actemra 200;TocilizuMab;Tocilizumab-Actemra;Tocilizumab,Atlizumab;anti-IL-6R Tocilizumab;Tocilizumab (anti-IL-6R)
- CBNumber:
- CB32735437
- Molecular Formula:
- C14H12O3
- Molecular Weight:
- 0
- MDL Number:
- MFCD01633115
- MOL File:
- Mol file
Last updated:2023-05-21 10:59:17
| storage temp. | Store at -80°C |
|---|---|
| solubility | Soluble in DMSO |
| FDA UNII | I031V2H011 |
| NCI Dictionary of Cancer Terms | Actemra; tocilizumab |
| NCI Drug Dictionary | Actemra |
| ATC code | L04AC07 |
TocilizuMab price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | ATB0023425 | TOCILIZUMAB 95.00% | 375823-41-9 | 5MG | $503.02 | 2021-12-16 | Buy |
| Biosynth Carbosynth | BT165595 | Tocilizumab | 375823-41-9 | 1mg | $600 | 2021-12-16 | Buy |
| ChemScene | CS-0028521 | Tocilizumab 99.67% | 375823-41-9 | 5mg | $670 | 2021-12-16 | Buy |
| ChemScene | CS-0028521 | Tocilizumab 99.67% | 375823-41-9 | 1mg | $280 | 2021-12-16 | Buy |
| ChemScene | CS-0028521 | Tocilizumab 99.67% | 375823-41-9 | 25mg | $2500 | 2021-12-16 | Buy |
TocilizuMab Chemical Properties,Uses,Production
Clinical Use
Interleukin inhibitor:
Treatment of rheumatoid arthritis in combination with methotrexate
Drug interactions
Potentially hazardous interactions with other drugs
Live vaccines: avoid concomitant administration
Metabolism
Tocilizumab undergoes biphasic elimination from the circulation. The total clearance of tocilizumab is concentration-dependent and is the sum of the linear and non-linear clearance. The concentration-dependent non-linear clearance plays a major role at low tocilizumab concentrations. Once the non-linear clearance pathway is saturated, at higher tocilizumab concentrations, clearance is mainly determined by the linear clearance.
TocilizuMab Preparation Products And Raw materials
Raw materials
Preparation Products
TocilizuMab Suppliers
Global( 78)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hangzhou FandaChem Co.,Ltd. | 008657128800458; +8615858145714 | fandachem@gmail.com | China | 9338 | 55 |
| Hebei Guanlang Biotechnology Co., Ltd. | +86-19930503282 | alice@crovellbio.com | China | 8829 | 58 |
| Career Henan Chemica Co | +86-0371-86658258 15093356674; | laboratory@coreychem.com | China | 30255 | 58 |
| Shanghai Minbiotech Co., Ltd. | +8617315815539 | sales@minbiotech.com | CHINA | 129 | 58 |
| AFINE CHEMICALS LIMITED | +86-0571-85134551 | info@afinechem.com | China | 15396 | 58 |
| Wuhan Fortuna Chemical Co., Ltd | +86-027-59207850 | info@fortunachem.com | China | 6000 | 58 |
| Hefei Hirisun Pharmatech Co., Ltd | +8615056975894 | shawn@hirisunpharm.com | CHINA | 9923 | 58 |
| Guangzhou TongYi biochemistry technology Co.,LTD | +8613073028829 | mack@tongyon.com | China | 2996 | 58 |
| Hebei Duling International Trade Co. LTD | +8617333973358 | sales01@hbduling.cn | China | 15568 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354 | support@targetmol.com | United States | 19973 | 58 |
View Lastest Price from TocilizuMab manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2023-11-27 | TocilizuMab
375823-41-9
|
US $0.00 / g | 1g | 99% | 50kg | Wuhan Senwayer Century Chemical Co.,Ltd | |
 |
2021-11-20 | TocilizuMab
375823-41-9
|
US $10.00 / KG | 100KG | 99% | 100 mt | Hebei Guanlang Biotechnology Co., Ltd. | |
 |
2021-09-29 | Tocilizumab
375823-41-9
|
US $0.00-0.00 / g | 1g | 99% | 100G | WUHAN FORTUNA CHEMICAL CO., LTD |
-
- TocilizuMab
375823-41-9
- US $0.00 / g
- 99%
- Wuhan Senwayer Century Chemical Co.,Ltd
-
- TocilizuMab
375823-41-9
- US $10.00 / KG
- 99%
- Hebei Guanlang Biotechnology Co., Ltd.
-
- Tocilizumab
375823-41-9
- US $0.00-0.00 / g
- 99%
- WUHAN FORTUNA CHEMICAL CO., LTD
375823-41-9(TocilizuMab)Related Search:
TocilizuMab
Actemra 200
R 1569
RoActemra
Tocilizumab,Atlizumab
anti-IL-6R Tocilizumab
Tocilizumab (anti-IL-6R)
Tocilizumab-Actemra
Actemra
Atlizumab
Research Grade Tocilizumab(DHC36902)
COVID-19,IL-6R,Anti-Human IL6R, Humanized Antibody,rheumatoid,respiratory failure,antibody,Interleukin Related,coronavirus disease,Tocilizumab,arthritis,inhibit,dyspnoea,Neutralizing,Inhibitor
375823-41-9
API